US stocks close lower on more tariff threats, data showing prices up and employment down

US stocks closed lower amid renewed tariff threats from President Trump on pharmaceuticals and semiconductors, alongside plans to significantly raise tariffs on India. This market downturn was exacerbated by economic data showing the ISM services price index reaching its highest level since October 2022, while the employment index contracted for the fourth time in five months. The data intensified expectations for a Federal Reserve rate cut, with the CME FedWatch tool indicating over a 91% probability for a September cut, overshadowing a mixed corporate earnings season.

Analysis

US equity markets closed lower, pressured by a combination of stagflationary economic signals and heightened geopolitical trade risk. The Institute for Supply Management's (ISM) services data presented a challenge for the Federal Reserve, with its price index climbing to the highest level since October 2022 while its employment index contracted for the fourth month in five. Despite this inflationary pressure, market expectations for a September rate cut have surged, with the CME FedWatch tool indicating a probability over 91%, up from the 60% range a week prior. This optimism was counteracted by President Trump's threats to impose significant new tariffs on pharmaceuticals and semiconductors and increase existing tariffs on India. The corporate earnings season reflects a highly bifurcated market; strong results and outlooks from tech firms like Palantir (+7.85%) and Axon (+16.41%) and a major M&A premium for Staar Surgical (+46.13%) contrasted sharply with weak results from consumer-facing firms like Yum Brands (-5.1%) and Denny's (-2.75%), and significant guidance cuts or clinical failures from companies like Inspire Medical (-32.35%) and Vertex Pharmaceuticals (-20.6%). Caterpillar's missed profit estimates, explicitly citing tariff impacts on margins, provide a tangible example of the risks from the current trade policy environment.

Key Decisions for Investors

• Investors should exercise caution and potentially hedge exposure in the pharmaceutical and semiconductor sectors, as well as companies with significant trade links to India, given the explicit tariff threats and their demonstrated impact on corporate margins like Caterpillar's.
• Given the stark divergence in corporate performance, a stock-picker's approach is warranted, favoring companies with strong execution and upwardly revised guidance like Palantir and Pfizer, while being wary of consumer-discretionary names and firms that have slashed their outlooks like Inspire Medical.
• While the market is aggressively pricing in a September Fed rate cut, the conflicting signal from the high ISM services price index introduces volatility risk; monitor upcoming inflation data closely as any surprise could abruptly shift rate expectations and market sentiment.
• Pay close attention to company-specific, event-driven situations, such as the announced acquisition of Staar Surgical or the clinical trial failure at Vertex, as these catalysts are currently driving more significant price action than broad market trends.